DIA Drug Information Association
DIA's members come together to collaborate and problem-solve, discussing global and local challenges facing the life sciences field in an increasingly more complex and interconnected world. DIA's goal, and our members' hope, is for this collaboration to result in better policies, regulations, science, research and development, and ultimately better patient outcomes worldwide.
|Type||Public / Private|
DIA fosters innovation to improve health and well-being worldwide by:
- Providing invaluable forums to exchange vital information and discuss current issues related to healthcare products, technologies, and services;
- Delivering customized learning experiences;
- Building, maintaining, and facilitating trusted relationships with and among individuals and organizations that drive and share DIA values and mandates; and
- Offering a multidisciplinary neutral environment, respected globally for integrity and relevancy.DIA Vision
DIA is your essential partner in catalyzing knowledge creation and sharing to accelerate healthcare product development.
Starting with the controversy over the drug Thalidomide, DIA’s founders - a group of 30 pharmaceutical professionals, medical writers, and academics - came together to create a platform for necessary global communication and collaboration to solve a healthcare threat to unborn children worldwide.
Today, professionals from 80 countries continue to engage with DIA through our unparalleled membership network, educational offerings, and professional development opportunities.
Top 5 Recent Tweets
|November 23, 2020||Staburo||Staburo GmbH Disclosure Manager Maarten van Dijk participated in the 2020 Global Clinical Trial Disclosure & Data T… https://t.co/loxzwxMamG|
|November 17, 2020||InspiredHealth_||Join us today for the Drug Information Association D&I Monthly Community meeting. On our agenda - review the finali… https://t.co/ewj5wKg3hV|
|November 16, 2020||InspiredHealth_||Join us tomorrow for the Drug Information Association D&I Monthly Community meeting. On our agenda - review the fin… https://t.co/sLhb3CFu01|